From Health Canada
New funds to bring total investment in public education, awareness and surveillance to $46M
October 31, 2017 Ottawa, ON Government of Canada
The Government of Canada introduced legislation to legalize, strictly regulate and restrict access to cannabis to keep it out of the hands of Canadian youth and the profits from criminals and organized crime. With this in mind, the Government intends to make significant investments in public education to inform Canadians, particularly youth and young adults, about the health and safety risks of cannabis.
Today the Government announced a new investment of $36.4M over the next five years for a cannabis education and awareness campaign. The funding will be used to inform Canadians, including youth and other priority populations such as Indigenous peoples, pregnant and breastfeeding women, and Canadians with a history of mental illness, of the health and safety risks of cannabis use and drug-impaired driving.
This new investment is in addition to the initial $9.6M over five years for a comprehensive public education and awareness campaign and surveillance activities announced in Budget 2017.
Public education and awareness efforts will include factual and evidence-based information on the health and safety risks of cannabis use and drug-impaired driving. The campaign will build on ongoing social media efforts, advertising and interactive events to engage youth on the facts. Subject to Parliamentary approval, the Government will expand its public education campaign to include information on the new laws, so Canadians will know what to expect in July 2018.
“We are tackling the issue of cannabis use with long-term investments in our education and awareness efforts. We want to make sure all Canadians, particularly our young adults and youth, understand the health and safety risks of cannabis. These efforts also aim to equip parents and teachers with tools to have meaningful discussions with young Canadians about the risks of cannabis use.”
The Honourable Ginette Petitpas Taylor
Minister of Health
“Impaired driving is the leading criminal cause of death and injury in Canada, and drug-impaired driving has been increasing every year since 2009. Public education and awareness will help Canadians, especially youth and their parents, understand the potentially deadly risks of driving while impaired by cannabis or other drugs.”
The Honourable Ralph Goodale
Minister of Public Safety and Emergency Preparedness
“In order to make informed choices, Canadians need the real facts about the health and safety risks of cannabis use. Like other substances, such as tobacco and alcohol, there are real potential harms to using them. We need to invest in public education and awareness about the potential consequences for the health and safety of Canadians who choose to use cannabis.”
The Honourable Jody Wilson-Raybould
Minister of Justice and Attorney General of Canada
“Our Government wants Canadians to have clear, factual information so that they understand how using cannabis could affect them. Our investment today is another step in informing Canadians, especially youth and young adults, about the real effects of cannabis.”
Parliamentary Secretary to the Minister of Justice and Attorney General of Canada and to the Minister of Health
“Cannabis use carries health risks, especially for youth. A public health approach will ensure that Canadians have access to the facts, to help them understand the health impacts around cannabis use and to encourage them to make the most informed decisions possible. This evidence-based public education campaign will help to reduce the negative health and social outcomes related to cannabis use.”
Dr. Theresa Tam
Chief Public Health Officer of Canada
•Today’s announcement includes $22.5M over the first two years and $13.9M for the subsequent three years to inform Canadians of the health and safety risks of cannabis use and drug-impaired driving. These funds will support an ongoing campaign to continue raising awareness about the health and safety risks of cannabis use, particularly for youth and other priority populations such as Indigenous peoples, pregnant and breastfeeding women, and Canadians with a history of mental illness.
•Public Safety Canada will launch a public education and awareness campaign on the dangers of drug-impaired driving in the fall.
•In March 2017, Health Canada began an ongoing digital campaign targeting parents and encouraging them to talk to their children about cannabis. The next phase of the public education campaign focusing on health risks will target youth 13-17 years old, and young adults 18-24 years old, and will start in January 2018. Subject to Parliamentary approval of the proposed Cannabis Act, the campaign would expand to include information about the changing laws and will target the broader Canadian public.
•In partnership with Drug Free Kids Canada, Health Canada supported the creation of the Cannabis Talk Kit to give parents a tool to help them talk to their teens about cannabis. To date, more than 114,000 copies of this valuable resource have been distributed. The Talk Kit is available for download or can be ordered in hard copy online.
•Beginning in 2018, Health Canada’s Substance Use and Addictions Program (SUAP) is dedicating $3M annually for cannabis public education and awareness initiatives. This funding would be open to organizations that meet the criteria for SUAP funding.
•The Canadian Institutes of Health Research have issued a Catalyst Grant focusing on the health and social impacts of cannabis legalization and regulation in Canada. This grant of $1M will, in part, support research to understand how specific groups like youth, Indigenous peoples or persons living with mental health issues or problematic substance use, may be affected by cannabis legalization and regulation and how to maximize benefits and minimize harm to those groups through public education and other strategies.
•In addition to today’s announcement, the Government also announced that it will be hosting a Partnership Symposium on Cannabis Public Health Education and Awareness on November 10, 2017, to bring together national stakeholders and partners to identify priority actions and opportunities for partnership in raising awareness and educating the public about the risks of cannabis use.
• Cannabis Talk Kit from Drug Free Kids Canada
• Health Effects of Cannabis
• Driving While Impaired by a Drug
• Infographic: Marijuana – We’d Like You to Know
• Infographic: Status of Cannabis Laws in Canada
• Substance Use and Addictions Program
• CIHR Catalyst Grant
Office of the Minister of Health
Office of the Minister of Public Safety and Emergency Preparedness
Public Safety Canada
Health Canada and the Public Health Agency of Canada
Created: September 11, 2017
Last update: September 18, 2017
House of Commons Health Committee
considers BILL C-45 (cannabis, marijuana)
September 11, 2017 to September 15, 2017 recorded testimony on the government’s BILL C-45 (cannabis, marijuana).
Watch the hearings live on CPAC.ca
In Committee from the House of Commons Marijuana
Health committee – September 11, 2017 – Part 1
The committee reconvenes a week ahead of Parliament’s return to begin its hearings on C-45, the government’s bill to legalize marijuana. The proposed Cannabis Act would create a legal framework to control the production, distribution, sale and possession of recreational marijuana in Canada. Sales will be restricted to people age
Health committee – September 11, 2017 – Part 2
Former justice minister Anne McLellan, who chaired the federal task force on marijuana legalization, testifies as the committee continues its hearings on Bill C-45
Health committee – September 11, 2017 – Part 3
MPs continue their hearings on the government’s cannabis legislation (C-45), with a panel on provincial responsibilities and perspectives from the cannabis industry. The committee hears from Philippe Lucas (executive director, Canadian Medical Cannabis Council), Keith Jones (chair, government relations) and Robert Rae (director), both with the Canadian Hemp Trade Alliance
Health committee – September 11, 2017 – Part 4
Canadian Medical Association president Laurent Marcoux and his colleague Jeff Blackmer (vice-president of medical professionalism) are among the witnesses to testify as the committee continues its review of C-45, the federal government’s marijuana legalization bill. MPs also hear from Trevor Bhupsingh (director general, Law Enforcement and Border Strategies Directorate
Health committee – September 12, 2017 – Part 1
The following witnesses testify on Bill C-45: Thomas Carrique (deputy chief) and Mike Serr (deputy chief constable, drug advisory committee), who are all representing the Canadian Association of Chiefs of Police; Rick Barnum (deputy commissioner, investigation and organized crime) from the Ontario Provincial Police; and Mark Chatterbok (deputy chief of operations) with the Saskatoon Police Service
Health committee – September 12, 2017 – Part 2
The committee discusses justice and public safety issues as it continues its hearings on the government’s marijuana legislation (C-45). MPs hear from Neil Boyd (criminology professor, Simon Fraser University); Christian Leuprecht (political science professor, Royal Military College of Canada); Barreau du Québec representatives Paul-Matthieu Grondin (president), Luc Hervé Thibaudeau
Health committee – September 12, 2017 – Part 3
The committee hears about the experiences of other jurisdictions as it continues its review of the government’s marijuana legislation (C-45). The witnesses are Sam Kamin (professor of marijuana law and policy, University of Denver); Michael Hartman (executive director, Colorado Department of Revenue); Marc-Boris St-Maurice (NORML Canada) and Abigail Sampson (NORML Canada)
Health committee – September 12, 2017 – Part 4
MPs continue their review of Bill C-45, the federal government’s proposal to legalize marijuana. Committee members hear from Marco Vasquez (retired Colorado police chief), Andrew Freedman (Colorado’s former director of marijuana coordination) Kevin Sabet (president, Smart Approaches to Marijuana), and Kristi Weeks (government relations director, Washington State Department of Health)
Health committee – September 13, 2017 – Part 1
The committee holds its third day of hearings on C-45, the federal government’s Cannabis Act.
Jonathan Page (chief executive officer, Anandia Labs), John Conroy (criminal defence lawyer) (president NORML Canada) and John Dickie (president, Canadian Federation of Apartment Associations) take part in a panel on the household cultivation of cannabis plants. Under the proposed bill, adults would legally be able to grow up to four plants per household.
Health committee – September 13, 2017 – Part 2
MPs hear from Scott Bernstein (senior policy analyst, Canadian Drug Policy Coalition); Ian Culbert (executive director, Canadian Public Health Association); Dr. Christina Grant (member of the Canadian Paediatric Society’s adolescent health committee); Judith Renaud and Paul Renaud (respectively executive director and communications director, Educators for Sensible Drug Policy); and Peter A. Howlett (president)and Peter Vamos (executive director), both representing the organization Portage, which operates drug rehabilitation programs.
Health committee – September 13, 2017 – Part 3
MPs hear from the following witnesses on Bill C-45: Amy Porath (director of research and policy, Canadian Centre on Substance Use and Addiction); Drug Free Kids Canada representatives Marc Paris (executive director) and William J. Barakett (member of advisory council); and Maude Chapados and François Gagnon (scientific advisors, Institut national de santé publique du Québec).
Health committee – September 13, 2017 – Part 4
The following witnesses offer their viewpoints: Dr. Gabor Maté (addiction expert); Centre for Addiction and Mental Health representatives Benedikt Fischer (senior scientist, Institute for Mental Health Policy Research) and Bernard Le Foll (medical head, Addiction Medicine Service, Acute Care Program); Dr. Eileen de Villa (Toronto’s medical officer of health); Dr. Sharon Levy (director of the Adolescent Substance Abuse Program at Boston Children’s Hospital); as well as Michelle Suarly and Elena Hasheminejad (members of Ontario Public Health Association’s Cannabis Task Group).
Health committee – September 14, 2017 – Part 1
The following witnesses discuss prevention, treatment, and low-risk use: Michael DeVillaer (assistant professor, department of psychiatry and behavioural neurosciences, McMaster University); Mark Kleiman (professor of public policy, Marron Institute of Urban Management, New York University; Lynda G. Balneaves, (medical and non-medical cannabis researcher) and Karey Shuhendler (policy advisor, policy, advocacy and strategy), both from with the Canadian Nurses Association; Dr. Serge Melanson (New Brunswick Medical Society); and Dr. Robert Strang (Nova Scotia’s chief medical officer of health).
Health committee – September 14, 2017 – Part 2
Trina Fraser (lawyer and cannabis law expert) and Norm Keith (lawyer specializing in occupational health and safety) testify. Brenda Baxter, an official with the Department of Employment and Social Development’s workplace directorate, is the other witness.
Health committee – September 14, 2017 – Part 4 (3)
Witnesses discuss labelling and packaging as the committee holds another hearing on the government’s cannabis legislation (C-45). The panellists are David Hammond (professor, University of Waterloo’s School of Public Health and Health Systems), Mike Hammoud (president Atlantic Convenience Stores Association), and Non-Smokers’ Rights Association representatives Melodie Tilson (director of policy) and Pippa Beck (senior policy analyst).
Health committee – September 14, 2017 – Part 5 (4)
The witnesses for this panel are Steven Hoffman (professor, York University’s Faculty of Health), Beau Kilmer (co-director, RAND Drug Policy Research Centre), Kirk Tousaw, (criminal defence lawyer) (NORML Canada) and advocate for repealing cannabis prohibition), and Stephen Rolles (senior policy analyst, Transform Drug Policy Foundation).
Health committee – September 15, 2017 – Part 1
Ryan Vandrey (associate professor of psychiatry and behavioral sciences at Johns Hopkins University), Daniel Vigil (manager of marijuana health monitoring and research, Colorado Department of Public Health and Environment) and Dana Larsen (director, Sensible BC) are the witnesses for this panel.
Health committee – September 15, 2017 – Part 2
The witnesses for this session are BC Compassion Club Society representatives Hilary Black (founder) and Marcel Vandebeek (administrator), Jonathan Zaid (executive director) and Daphnée Elisma (Quebec representative), who are both with the group Canadians for Fair Access to Medical Marijuana, and the Department of Health’s Jacqueline Bogden (assistant deputy minister, Cannabis Legalization and Regulation Branch).
Health committee – September 15, 2017 – Part 3
Marijuana activists Marc and Jodie Emery take part in the committee’s hearings on Bill C-45, the federal government’s proposal to legalize recreational marijuana.
Lisa Holmes (mayor of Morinville, Alberta and president of the Alberta Urban Municipalities Association), Brock Carlton (CEO, Federation of Canadian Municipalities) and Bill Karsten (second vice-president, FCM) are the other witnesses for this panel on municipalities.
September 11, 2017
Health committee hears from senior government officials, RCMP on pot legislation
A senior RCMP officer says it would be “naive” to think organized crime in the cannabis market will be eliminated with the legalization of recreational marijuana.
2017 has proven to be a historic year in cannabis history. Through our annual conference, we bring together experts from all walks of the cannabis space, to help educate and engage Canadians in open, productive and thoughtful dialogue.
Saturday, September 9th, 2017
11:00 AM – NORML Canada – Opening Address
11:15 AM – Jamie Shaw (MMJ Canada), Irie Sellkirk (Emblem), Dessy Pavlova (CSSDP/Lift), Amy Brown (Canndo) – Women and Cannabis Panel
12:30 PM – Britney Guerra – Cannabis Entrepreneurship – Challenges and Triumphs
1:30 PM Lunch Break
2:00 PM – Alison Gordon – Navigating Businesses into the Legal Cannabis Market
3:00 PM – Marcus Richardson (Bubbleman), Kevin Furet (Cannabis Wheaton), Jose Domingez (Canveda), Matt Rogge (7Acres) – Cannabis Growing- Personal, Patients and Large Production
4:00 PM – Dana Larsen – Keynote
5:00 PM – Marcus Richardson – Bubbleman Brand
6:00 PM – Jodie Emery – The Princess of Pot
7:00 PM – NORML Canada – Closing Day 1 Remarks – John Conroy
Sunday September 10th
11:00 AM – NORML Canada – Welcome
11:15 AM – MP Nathaniel Erskine Smith – Keynote
12:30 PM – David Schaefer (BHOGart) Safe Extraction Methods
1:30 PM – Lunch
2:00 PM – Alan Park – Canadian Comedian Cures Cancer with Cannabis Oil
3:00 PM – Adam Greenblatt (Canopy Growth), Matt Mernagh (Peace Naturals), John Fowler (Supreme), Kevin Furet (Cannabis Wheaton), Shega Youngson (Canopy Growth) – From Grey to Green – Transitioning Into the Legal Cannabis Market.
4:00 PM – Paul Lewin – Dispensaries- The Legal Challenges and Legalization
5:00 PM – Executive Directors of NIMCA – the National Indigenous Medical Cannabis Association
6:00 PM – Jonathan Zaid (CFAMM) – Cannabis and Driving
6:30 PM – NORML Canada Conference Closing Remarks – John Conroy
June 9, 2017
(R. v. Elliott, 2016 BCSC 1135, Kelowna Docket 78741).
Counsel for the Respondent: John W. Conroy Q.C., NORML Canada President
Mandatory minimum imprisonment for cannabis cultivation of 6 to 200 cannabis plants “grossly disproportionate”, “unconstitutional”
“The Court affirmed the sentencing judge’s conclusion that s. 7(2)(b)(i) is an unconstitutional violation of s. 12 of the Charter and is of no force and effect pursuant to s. 52 of the Constitution Act, 1982”
On appeal from: An order of the Supreme Court of British Columbia, dated May 4, 2016 (R. v. Elliott, 2016 BCSC 1135, Kelowna Docket 78741)
Counsel for the Appellant: P.A. Eccles
Counsel for the Respondent: J.W. Conroy, Q.C.and M.J. Jackson
Place and Date of Hearing: Kelowna, British Columbia January 31, 2017
Place and Date of Judgment: Vancouver, British Columbia June 9, 2017
We can’t help but feel the cannabis act is more decriminalization then legalization. Also of much concern is the criminal penalties and restrictions are much more harsher for cannabis then alcohol, tobacco and even many violent crimes.
Note: The impaired driving likely won’t hold up to constitutional challenges in the courts. calgary420.ca/pdf/driving/driving-impaired.pdf
Growing restricted to 4 plants per home and 1 meter height max. Tobacco cultivation limit is 15kg per year for each adult person living at the residence.
Note: Easy enough to control height with plant training.
April 13, 2017
Government of Canada news release (legalize cannabis legislation) (PDF)
Government of Canada Cannabis Act (PDF)
April 13, 2017
Emily Mertz, Web Producer – Global News Calgary
What do you think the legal minimum age to buy marijuana in Alberta should be?
See age poll left side after “City of Calgary” and before “Calgary 420 Cannabis Community”
September 4, 2002 marks the release of the Senate Special Committee on Illegal Drugs: “Cannabis: Our Position for a Canadian Public Policy.” with a recommended 16 year old age limit for consuming cannabis.
April 13, 2017
Shaun Frenette – CTV Calgary News
Re: Concerns about youth and driving under proposed marijuana laws.
Cannabis and impaired driving – PDF document calgary420.ca/pdf/driving/driving-impaired.pdf
Re: Calgary Mayor Naheed Nenshi brain science comment:
The long term real world schizophrenia data from the nineteen sixties (1960s) to twenty sixteen (2016) shows no sufficient increases even thought cannabis consumption has sufficiently increased over the same time period (over 50 years).
April 15, 2017
Mike Blanchard – 660 News Radio
A local marijuana advocate is urging the Alberta government to keep pot out of liquor stores once the stuff becomes legal